SCOPUS 정보 검색 플랫폼

Volumn 16, Issue 4, 2001, Pages 225-234

A phase II trial of fractionated vinorelbine/doxorubicin as first-line therapy for advanced breast cancer

(13) Hegg, R a Costa, M A b Perdicaris, M c Delgado, G L d Cabral Filho, S e Malzyner, A f Caponero, R f Yamagushi, N g Novaes, N e Anelli, A h Correa, M h Nader, L d Andrade, C b

a UNIVERSITY OF SÃO PAULO (Brazil)

b INSTITUTO NACIONAL DE CÂNCER (Brazil)

c Hospital da Sociedade Portuguesa de Beneficência de Santos (Brazil)

d Conjunto Hospitalar ^* (Brazil)

e Santa Casa de Misericordia de Goiania (Brazil)

f Clínica de Oncologia Medica (Brazil)

g Instituto Avanços em Medicina (Brazil)

h A C CAMARGO CANCER CENTER (Brazil)

Author keywords

Advanced breast cancer; First line therapy; Fractionated doxorubicin; Vinorelbine

Indexed keywords

ANTHRACYCLINE; DOXORUBICIN; NAVELBINE; PACLITAXEL;

ADVANCED CANCER; ALOPECIA; ARTICLE; BLOOD TOXICITY; BREAST CANCER; CANCER SURVIVAL; CARDIOTOXICITY; CLINICAL TRIAL; CONSTIPATION; DISEASE COURSE; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG TOLERANCE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; METASTASIS; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; PHLEBITIS; TREATMENT OUTCOME;

ALOPECIA; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CAUSE OF DEATH; COMBINED MODALITY THERAPY; CONSTIPATION; DOXORUBICIN; DRUG ADMINISTRATION SCHEDULE; DRUG MONITORING; FEMALE; HEART DISEASES; HUMANS; NEOPLASM STAGING; NEUTROPENIA; PHLEBITIS; PROPORTIONAL HAZARDS MODELS; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VINBLASTINE;

EID: 17744382769 PISSN: 03007995 EISSN: None Source Type: Journal
DOI: 10.1185/030079901750176726 Document Type: Article

Times cited : (6)

References (26)

1
- 0003193675
- Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy
- (1992) Lancet , vol.339 , pp. 1-15

2
- 0021954886
- Improved survival of patients with metastatic breast cancer receiving combination chemotherapy
- (1985) Cancer , vol.55 , pp. 341-346
- Ross, M.B.¹ Budzar, A.U.² Smith, T.L.³

3
- 0030248579
- Impact of scheduling on toxicity and clinical efficacy of doxorubicin: What do we know in the mid-nineties?
- (1996) Eur. J. Cancer , vol.32 A , Issue.10 , pp. 1652-1660
- Bielack, S.S.¹ Erttmann, R.² Kempf-Bielack, B.³ Winkler, K.⁴

4
- 0029786845
- Combined doxorubicin and paclitaxel in advanced breast cancer: Effective and cardiotoxic
- (1996) Ann. Oncol. , vol.7 , pp. 687-693
- Gehl, J.¹ Boesgaard, M.² Paaske, T.³ Vittrup Jensen, B.⁴ Dombernowsky, P.⁵

5
- 0017199039
- Studies of adriamycin using a weekly regimen demonstrating its clinical effectiveness and lack of cardiac toxicity
- July
- (1976) Cancer Treat. Rep. , vol.60 , Issue.7
- Weiss, A.J.¹ Metter, G.E.² Fletcher, W.S.³

6
- 0019995342
- Increased relative effectiveness of doxorubicin against slowly proliferating sarcoma 180 cells after prolonged drug exposure
- (1982) Cancer Treat. Rep. , vol.66 , pp. 1159-1168
- Ritch, P.S.¹ Occhipinti, S.J.² Skramstad, K.S.³

7
- 0018900529
- Adriamycin given as a weekly schedule without a loading course: Clinically effective with reduced incidence of cardiotoxicity
- (1980) Cancer Treat. Rep. , vol.64 , pp. 47-51
- Chlebowki, R.¹ Paroly, W.² Pugh, R.³

8
- 0001212761
- A comparative trial of three schedules for single-agent doxorubicin in advanced breast cancer: An aborted investigation
- (1992) J. Infus. Chemother. , vol.2 , pp. 185-188
- Lokich, J.¹ Auerbach, M.² Smith, L.³ Cantrell, J.⁴ Fryer, J.⁵ Alt, D.⁶

9
- 0027253398
- Phase II trial of weekly intravenous vinorelbine in firstline advanced breast chemotherapy
- (1993) J. Clin. Oncol. , vol.11 , pp. 1245-1252
- Fumoleau, P.¹ Delgado, F.² Delozier, T.³ Monnier, A.⁴ Gil Delgado, M.⁵ Kerbrat, P.⁶ Garcia-Giralt, E.⁷ Keiling, R.⁸ Namer, M.⁹ Closon, M.¹⁰ Goudier, M.¹¹ Chollet, P.¹² Lecourt, L.¹³ Montcuquet, P.¹⁴

10
- 0027973756
- Phase II trial of vinorelbine/doxorubicin as first line therapy of advanced breast cancer
- (1994) J. Clin. Oncol. , vol.12 , pp. 1764-1770
- Spielmann, M.¹ Dorval, T.² Turpin, F.³ Antoine, E.⁴

11
- 0033008715
- A prospective, randomised phase III trial comparing combination chemotherapy with cyclophosphamide, and 5-fluorouracil with navelbine plus doxorubicin in the treatment of advanced breast cancer
- 1999
- (1999) Cancer , vol.85 , pp. 1091-1097
- Blajman, C.¹ Balbiani, L.² Coppola, E.³ Bader, M.⁴

12
- 0019365237
- Reporting results of cancer treatment
- 1981
- (1981) Cancer , vol.47 , pp. 207-214
- Miller, A.B.¹ Hoogstraten, B.² Stagnet, M.³

13
- 0004004274
- Lippincott
- (1990) Cancer Chemotherapy: Principles and Practice
- Chabner, B.¹ Collins, J.²

14
- 0021063443
- Reduced cardiotoxicity of doxorubicin delivery on a weekly schedule. Assessment by endomyocardial biopsy
- (1983) Ann. Intern. Med. , vol.99 , pp. 745-749
- Torti, F.¹ Bristow, M.² Howes, A.³

15
- 0000232194
- Navelbine and fractionated dose doxorubicin improves first line advanced breast cancer chemotherapy. An overview of 3 phase II trials
- Abstract 649
- (1997) Eur. J. Cancer , vol.33 , Issue.SUPPL. 8
- Carmichael, J.¹ Hegg, R.² Firat, D.³ Pawlicki, M.⁴ Delgado, F.⁵ Hill, S.⁶ Danel, P.⁷ Le Bras, F.⁸

16
- 0005844448
- Phase II study of IV navelbine and doxorubicin in previously untreated advanced breast cancer
- Abstract 693
- (1997) Proc. Am. Soc. Clin. Oncol. , vol.16 , pp. 197
- Vorobiof, D.¹ Goedhals, L.² Barnardt, P.³ Gudgeont, A.⁴ Van der Merwe, A.⁵ Smith, L.⁶ Murray, E.⁷ Pretorius, D.⁸ Bassompierre, P.⁹ Bergonzoli, E.¹⁰ Delgado, F.¹¹ Le Pape, I.¹² Burillon, J.¹³ Le Couturier, S.¹⁴

17
- 0000318934
- A phase III comparative study of vinorelbine combined with doxorubicin vs. doxorubicin alone in metastatic/recurrent breast cancer
- Abstract 59
- (1996) Proc. Am. Soc. Clin. Oncol. , vol.15 , pp. 98
- Norris, B.¹ Pritchard, K.² James, K.³ Myles, J.⁴ Bennett, K.⁵ Marlin, S.⁶ Skillings, J.⁷ Findlay, B.⁸ Goss, P.⁹ Latreille, J.¹⁰ Lopez, P.¹¹ Osoba, D.¹² Rodgers, A.¹³

18
- 0029014102
- Combined doxorubicin/vinorelbine (Navelbine) therapy in the treatment of advanced breast cancer
- (1995) Semin. Oncol. , vol.11 , Issue.SUPPL. 5 , pp. 55-60
- Hochster, H.¹

19
- 0005799931
- Phase II study of sequential Navelbine and doxorubicin for the treatment of metastatic breast cancer: Preliminar results
- Abstract 65
- (1996) Proc. Am. Soc. Clin. , vol.15 , pp. 100
- Costa, M.¹ Cabral-Filho, S.² Correa, M.³ Yamaguchi, N.⁴ Novaes, N.⁵ Andrade, C.⁶ Agnelli, A.⁷ Rodrigues, T.⁸ Malzyner, A.⁹ Caponero, R.¹⁰ Delgado, G.¹¹ Perdicaris, M.¹² Martinez, A.¹³ Fraga, J.¹⁴ Le Pape, I.¹⁵ Delgado, F.¹⁶ Hegg, R.¹⁷

20
- 0002644290
- Navelbine and doxorubicin combination (D1-D8) in advanced breast carcinoma previously untreated
- Abstract 108P
- (1996) Ann. Oncol. , vol.7 , pp. 25
- Firat, D.¹ Baltali, E.² Içli, F.³ Berk, O.⁴ Uskent, N.⁵ Danel, P.⁶ Le Pape, I.⁷ Delgado, F.⁸

21
- 0001778419
- A multicenter phase II study of Navelbine and doxorubicin as first line chemotherapy in advanced breast cancer: Preliminary results
- Abstract 114P
- (1996) Ann. Oncol. , vol.7 , pp. 26
- Pawlicki, M.¹ Siedlecki, P.² Zaluski, A.³ Ramlau, R.⁴ Rolski, J.⁵ Burillon, J.⁶ Le Bras, F.⁷ Delgado, F.⁸ Maj, S.⁹

22
- 0015849162
- A clinico-pathologic analysis of adriamycin cardiotoxicity
- (1973) Cancer , vol.32 , pp. 302-314
- Lefrack, E.¹ Pitha, J.² Rosenheim, S.³

23
- 0022897407
- Weekly adriamycin versus VAC in advanced breast cancer. A randomised trial
- (1986) Eur. J. Clin. Oncol. , vol.11 , pp. 1431-1434
- Gundersen, S.¹ Kvinnsland, S.² Klepp, O.³ Kvaloy, S.⁴ Lunds, E.⁵ Host, H.⁶

24
- 0017199039
- Studies on adriamycin using a weekly regimen demonstrating its clinical effectiveness and lack of cardiac toxicity
- (1976) Cancer Treat. Rep. , vol.60 , pp. 813-822
- Weiss, A.¹ Metter, G.² Fletcher, W.³ Wilson, W.⁴ Grage, T.⁵ Ramirez, G.⁶

25
- 0028877036
- Paclitaxel by 3-hour infusion in combination with bolus doxorubicin in women with untreated metastatic breast cancer: High antitumour efficacy and cardiac effects in a dose-finding and sequencefinding study
- (1995) J. Clin. Oncol. , vol.13 , pp. 2688-2699
- Gianni, L.¹ Munzone, E.² Capri, G.³

26
- 0032834188
- Phase II study of epirubicin and vinorelbine with granulocyte colony-stimulating factor: A high-activity, dose dense weekly regimen for advanced breast cancer
- (1999) Ann. Oncol. , vol.10 , pp. 937-942
- Nisticò, C.¹ Garufi, C.² Barni, S.³ Galla, D.⁴ Giannarelli, D.⁵ Vaccaro, A.⁶ D'Ottavio, A.⁷ Terzoli, E.⁸

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.